Dr. Thomas J. Fahey III - Endocrine and Minimally Invasive Surgery

Dr. Fahey serves as Vice Chair of the Department of Surgery and Chief of Endocrine and Minimally Invasive Surgery at Weill Cornell Medicine. He directs the Endocrine Oncology Program and holds the Johnson & Johnson Distinguished Professorship of Surgery. He practices at NewYork-Presbyterian/Weill Cornell Medical Center.

 

His research focuses on translational therapies for endocrine tumors. He led the first U.S. use of 5-aminolevulinic acid to guide fluorescence in adrenal and thyroid surgery, securing FDA approval for high-grade lesion visualization. He investigates magnetic hyperthermia with iron-oxide nanoparticles to augment chemoradiation effects in preclinical models.

 

He mentors general surgery residents and endocrine surgery fellows in operative strategy, clinical trial design, and ethical decision-making. He chairs the Joint Tumor Section of the American Association of Neurological and American College of Surgeons and sits on boards of patient-advocacy foundations.